共 37 条
- [1] Rankine L., Wan H., Parikh P., Et al., Cone-beam computed tomography internal motion tracking should be used to validate 4-dimensional computed tomography for abdominal radiation therapy patients, Int J Radiat Oncol Biol Phys, 95, 2, pp. 818-826, (2016)
- [2] Seppenwoolde Y., Shirato H., Kitamura K., Et al., Precise and real-time measurement of 3D tumor motion in lung due to breathing and heartbeat, measured during radiotherapy, Int J Radiat Oncol Biol Phys, 53, 4, pp. 822-834, (2002)
- [3] Hamming V.C., Visser C., Batin E., Et al., Evaluation of a 3D surface imaging system for deep inspiration breath-hold patient positioning and intra-fraction monitoring, Radiat Oncol, 14, pp. 1-8, (2019)
- [4] Schwaab J., Prall M., Sarti C., Et al., Ultrasound tracking for intra-fractional motion compensation in radiation therapy, Physica Med, 30, 5, pp. 578-582, (2014)
- [5] Charters J.A., Abdulkadir Y., O'connell D., Yang Y., Lamb J.M., Dosimetric evaluation of respiratory gating on a 0.35-T magnetic resonance–guided radiotherapy linac, J Appl Clin Med Phys, 23, 9, (2022)
- [6] Godley A., Zheng D., Rong Y., MR-linac is the best modality for lung SBRT, J Appl Clin Med Phys, 20, 6, pp. 7-11, (2019)
- [7] Green O.L., Rankine L.J., Cai B., Et al., First clinical implementation of real-time, real anatomy tracking and radiation beam control, Med Phys, 45, 8, pp. 3728-3740, (2018)
- [8] Lee S.L., Mahler P., Olson S., Et al., Reduction of cardiac dose using respiratory-gated MR-linac plans for gastro-esophageal junction cancer, Med Dosim, 46, 2, pp. 152-156, (2021)
- [9] Redler G., Stevens T., Cammin J., Et al., Dosimetric feasibility of utilizing the viewray magnetic resonance guided linac system for image-guided spine stereotactic body radiation therapy, Cureus, 11, 12, (2019)
- [10] Tanabe Y., Kiritani M., Deguchi T., Hira N., Tomimoto S., Patient-specific respiratory motion management using lung tumors vs fiducial markers for real-time tumor-tracking stereotactic body radiotherapy, Phys Imaging Radiat Oncol, 25, (2023)